NL – Synthon v. Yeda

Posted: September 25th, 2017

Synthon B.V. v. Yeda Research & Development Co. Ltd, District Court The Hague, 6 September 2017, Case Number ECLI:NL:RBDHA:2017:10315 Yeda Research & Development Co., Ltd is the proprietor of EP 2 405 794, which claims a dosing regimen for glatiramer acetate (Copaxone®) for the treatment of Multiple Sclerosis. In proceedings before the District Court of […]


NL – High Point v. KPN / Supreme Court

Posted: September 18th, 2017

High Point SARL v. KPN B.V., Supreme Court of the Netherlands, 15 September 2017, Case no. ECLI:NL:HR:2017:2363 High Point holds EP 772 that relates to a ‘Wireless access telephone-to-telephone network interface architecture’. The Court of Appeal decided earlier that the claim limitations submitted by High Point per deed after having submitted its statement of appeal […]


NL – Becton Dickinson v. Braun Melsungen

Posted: September 14th, 2017

Becton Dickinson BV v. B. Braun Melsungen AG, District Court of The Hague, 6 September 2017, case no. 521541, ECLI:NL:RBDHA:2017:9997 This judgment of the District Court of The Hague concerns a nullity action lodged by Becton Dickinson B.V. against B. Braun Melsungen AG in relation to the (Dutch part of the) European patent EP 2 […]


NL – Smart Technologies v. CTouch Europe

Posted: August 1st, 2017

Smart Technologies ULC v. CTouch Europe B.V., District Court The Hague, 26 July 2017, Case No. ECLI:NL:RBDHA:2017:8247 Smart Technologies is the holder of a patent on smart television screens. CTouch’s Gillette defence fails as there is a theoretic and practical difference between its products and the prior art. Injunction and ancillary claims awarded. A copy […]


NL – Millennium v. Teva

Posted: July 31st, 2017

Millennium Pharmaceuticals Inc. v. Teva Nederland B.V., Pharmachemie B.V., Teva Pharma B.V., Teva Pharmaceuticals Europe B.V. and Teva API B.V., Summary Judge of the District Court of The Hague, 25 July 2017, Case no. ECLI:NL:RBDHA:2017:8259 The present dispute concerns an alleged infringement of the rights of Millennium Pharmaceuticals Inc. (“Millennium”) as vested in the Dutch […]


DE – Abdichtsystem

Posted: July 26th, 2017

“Abdichtsystem”, BGH, 16 May 2017, Case X ZR 120/15, reported by Nadine Heiartz and Dominik Woll, Bardehle Pagenberg German Federal Court of Justice on claims for recall and removal in Germany in case of acts performed abroad  In the present judgment, the German Federal Court of Justice (»BGH«) found that sales completely performed abroad may […]



Posted: July 5th, 2017

Intermarine S.p.A. (formerly Rodriquez Cantieri Navali S.p.A.) v. CMC Marine S.r.l.. Court of Appeal of Turin, Italy, 22 June 2017, Judgement no. 106/2016 With its writ of summons in the first instance proceedings, Intermarine demanded the Court of Turin a declaration of invalidity of a utility model owned by CMC. Said utility model related to […]


NL – Hygro International v. Futurecare Worldwide

Posted: June 22nd, 2017

Hygro International PTY Limited v. Futurecare Worldwide B.V. et al., District Court The Hague, The Netherlands, 21 June 2017, Case No. ECLI:NL:RBDHA:2017:6743 Futurecare did not respond to Hygro’s rebuttal of Futurecare’s invalidity arguments. Hygro therefore sufficiently established that it is entitled to the patent. Futurecare further did not dispute that the products marketed by them […]


UK – Chugai Pharmaceutical Co. Ltd v UCB Pharma S.A.

Posted: June 1st, 2017

Chugai Pharmaceutical Co. Ltd v (1) UCB Pharma S.A. and (2) Celltech R&D Limited, UK, High Court, Carr J, 26 May 2017 These proceedings concerned an application by Chugai Pharmaceuticals (“Chugai”) for a declaration that it was not obliged to continue to pay royalties under a patent licence granted by the First Defendant (“UCB”). The […]